- Home
- FSM vs CLDX Comparison
FSM vs CLDX Comparison
Compare FSM & CLDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | FSM | CLDX |
|---|---|---|
| Founded | 1990 | N/A |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Precious Metals | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
| Sector | Basic Materials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.7B | 2.6B |
| IPO Year | 2005 | 1995 |
Fundamental Metrics
Financial Performance| Metric | FSM | CLDX |
|---|---|---|
| Price | $8.33 | $36.78 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 1 | 10 |
| Target Price | $14.00 | ★ $46.60 |
| AVG Volume (30 Days) | ★ 4.8M | 1.2M |
| Earning Date | 05-06-2026 | 05-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $12,743,000.00 |
| Revenue This Year | $38.01 | $111.39 |
| Revenue Next Year | N/A | $235.85 |
| P/E Ratio | $14.10 | ★ N/A |
| Revenue Growth | N/A | ★ 87.78 |
| 52 Week Low | $6.17 | $19.72 |
| 52 Week High | $13.85 | $39.16 |
Technical Indicators
Market Signals| Indicator | FSM | CLDX |
|---|---|---|
| Relative Strength Index (RSI) | 39.63 | 70.15 |
| Support Level | $7.92 | $28.51 |
| Resistance Level | $10.13 | N/A |
| Average True Range (ATR) | 0.37 | 1.50 |
| MACD | -0.04 | 0.65 |
| Stochastic Oscillator | 14.44 | 75.79 |
Price Performance
Historical ComparisonAbout FSM Fortuna Silver Mines Inc (Canada)
Fortuna Mining Corp is a Canadian-based precious metals mining company with mines in the Latin America and West Africa regions producing gold and silver. It operate mines in Argentina, Burkina Faso, Cote d'voire, Mexico, and Peru. The company's segment consists of Mansfield, Sango, Bateas, Corporate. The company generates the majority of its revenue from Sango segment which operates the Seguela gold mine. Geographically, the company generates the majority of its revenue from Cote d' Ivoire location.
About CLDX Celldex Therapeutics Inc.
Celldex Therapeutics Inc is a biopharmaceutical firm focused on mast cell biology and the development of therapeutic antibodies. Its pipeline includes monoclonal and bispecific antibodies aimed at treating severe inflammatory, allergic, autoimmune, and other mast cell-mediated diseases. The company operates in a single operating and reportable segment in the business of development, manufacturing and commercialization of novel therapeutics for human health care.